FAS and Pelizeaus-Merzbacher spectrum disorder: Moreover, increased levels of the soluble ligand of protein FAS (sFAS-L) were observed in CHD patients with PMD, implying the involvement of apoptosis of cardiomyocytes and endothelial cells [2].